Background: ovarian cancer is the fifth most common form of cancer in the world and is often asymptomatic in its early stages. development of ovarian cancer-specific biomarkers for the early detection of disease could improve the current dismal survival rate. Evaluation of serum carbohydrate antigen 125 (CA125), alkaline phosphatase (alP) and oxidative stress in ovarian carcinoma patients may improve the prognosis of the disease through earlier detection. Aim of the study: The aim of this study was to find the relative risk of ovarian cancer in patients screened for CA125, ALP, Nitric oxide (NO) and Malondialdehyde (MdA) as a marker for lipid peroxidation. Material and methods: 451 subjects with ovarian cancer were screened for serum Ca125 levels using a chemiluminescence analyser, out of which 164 showed values above 21 u/ml. 80 subjects with higher values were further analysed for MDa and no using spectrophotometry and alP by fully automated chemistry analyser. Results: The selected 80 subjects with Ca125 values above 74 u/ml had increased alP, no and MDa, also showing positive correlation amongst these parameters. Conclusions: benefits of Ca125 screening vary with age group according to blood Ca125 levels. enzyme alP levels are elevated with higher values of Ca125. MDa and no indicate oxidative stress and increase as the ovarian marker values increase. Positive correlation amongst the parameters indicates a significant increase in oxidative stress in ovarian cancer. for women with various Ca125 levels in different age groups, screening and treatment depends upon individual decision and clinical examination.
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Background
Ovarian cancer accounts for 16% of cancers in females and is the 5th most common form of cancer in the world [1] . Most of these cancers are epithelial in origin [2] . unfortunately, the majority remain clinically undetected until the late stage and only 25% are detected during stage I, while 75% of women ultimately die of complications associated with disease progression. at present, screening methods include transvaginal ultrasound, smear studies, serum markers and or a combination of these [3] . Ca 125, alP, MDa, and no can be used in screening for early malignancy, diagnosis, determining prognosis, monitoring response to therapy, and postoperative surveillance. There is a great need for the development of ovarian cancerspecific biomarkers for early detection of disease [4] .
The most widely used marker in ovarian cancer is carbohydrate antigen 125 (Ca125), which is elevated in approximately 90% of patients with advanced epithelial ovarian cancer. Serum tumour makers have been used in clinical management for diverse cancers [5, 6] . oxidative stress has been described as a critical factor in tumour development; it is caused by a disturbed balance between production of reactive oxygen species (roS) and antioxidant defence. roS are involved in many physiological processes through the promo-Medical Science Pulse 2018 (12) 4 tion of genetic instability, abnormal cell proliferation, and angiogenesis [1, 7] . Potential biological targets for free radical attack are lipids, proteins and nucleic acids. lipid peroxidation causes loss of cell homeostasis by modifying the structure and limiting the usual functions of the cell membrane. oxidative stress on the cells increases as polyunsaturated fatty acids are degraded to generate MDa, which is a crucial component of the antioxidant system. It forms substantial Dna-Malondialdehyde (MDa) adducts by interacting with cellular Dna. The chance of cell survival diminishes as the integrity of the plasma membrane slowly falls, leading to apoptosis [1, 8] .
Cancer cells undergo metabolic reprogramming from oxidative phosphorylation to aerobic glycolysis during carcinogenesis. They rely primarily on aerobic glycolysis to sustain proliferation; this phenomenon is known as the "Warburg effect" [9] .
nitric oxide (no) is a highly reactive free radical which is synthesized by nitric oxide synthase (noS) in cells. no functions as a signal transducer regulating multiple physiological and pathological processes. Bacterial endotoxins, inflammatory cytokines, hypoxia and oxidative stress result in high production of no. noS and no have biphasic effects in carcinogenesis, tumour progression and therapy of tumours depending on the concentration and duration of no exposure in the tumour microenvironment [9] .
Alkaline phosphatase (ALP) is a ubiquitous enzyme present in all tissues but is mainly concentrated in the liver, kidney, placenta, and bone. In the musculoskeletal system, alP plays a role in mineralization of newly formed bone and serum alP is used to monitor primary bone lesions. In fact, elevated alP has been reported in severe primary bone lesions, and the possible role of ALP as a tumour marker in ovarian cancer has been suggested [6, 10] .
The purpose of the present study was to screen ovarian carcinoma patients for Ca-125, alP and oxidative stress to improve the early diagnosis of disease.
Aim of the study
Material and methods
451 subjects were selected from a group of patients with ovarian cancer by simple random sampling and screened for serum Ca125 levels from January 2014 to december 2016. The distribution variables were evaluated by a chi-square test. from the screened subjects, 80 cases and 80 controls were selected for the study and the t-test was applied. blood samples from each subject were collected in plain vacutainers, centrifuged and serum samples were preserved at -80°C. estimation of Ca125 was done by chemiluminescent immunoas-say (Chemiluminescent Immulite 1000), MDa and no by spectrophotometer (v670JASCO) and ALP by fully automated chemistry analyser (aDVIa). females from o.P.D. and I.P.D. of the Surgery and obgY (obstetrics and gynaecology) departments of grant government Medical College and Sir J. J. group of hospitals, Mumbai were included in the study. ethical clearance approval was received from the institutional ethics committee and informed consent was obtained from patients prior to the study. Statistical evaluation was done using Minitab 17 software with the t-test using a 95% confidence interval. all the statistical tests were two-sided and P < 0.05 was considered statistically significant.
Results
The distribution of screened subjects showed a high incidence of individuals with Ca125 levels above 21 u/ml. The screened subjects were grouped according to serum Ca125 level and age (tab. 1, 2, 3). out of the 451 screened subjects, 164 had higher values of CA125. Levels of oxidative stress markers and alkaline phosphatase were obtained in 80 subjects with Ca-125 levels above 74 u/ml and 80 controls (tab. 4). a positive correlation was established amongst Ca125, alP, MDa and no, and this was significantly increased in the ovarian cancer patients as compared to control subjects. The t-test was applied and the means and standard deviation values of the variables show the data is consistent with the normal distribution (tab. 5 and fig. 1 ). This study shows that CA-125 and alkaline phosphatase may increase with metastasis.
Discussion
In India, 15% of all gynaecological cancers are ovarian malignancies [11] . Ca125 measurement during follow-up can help to select the patients who may benefit from surgery and early therapy. We tested Ca125 and ALP as biomarkers and MdA and NO as oxidative and nitrosative stress markers. These markers have potential to improve risk, early detection, diagnosis, prognosis, monitoring and therapy (tab. 1-4). Ca125 represents an attractive therapeutic target and numerous groups have been developing approaches to it. for example, antibodies that bind unique or repeat domains of Ca125, anti-idiotype antibodies, and anti- www.medicalsciencepulse.com bodies that bind membrane-bound Ca125, have been coupled to cytotoxic drugs or fused with cytokines. All these approaches present great potential and should be aggressively pursued, particularly considering ovarian cancer's grim prognosis [12] [13] [14] .
In this study we found a significant increase in MDa and no levels (tab. 4) indicating lipid peroxidation in ovarian cancer patients (p =< 0.001) compared to healthy controls; this represents oxidative and nitrosative stress in ovarian cancer [11, 15] . Severe oxidative stress is not only known to cause dNA damage and mutations of tumour suppressor genes which are initial events in carcinogenesis but also can play an important role in the promotion of multistep carcinogenesis [1, 16] .
When the MDa level is considered along with Ca125, there is a greater correlation with ovarian cancer activity than when Ca125 is measured alone. Moreover, the severity of the cancer can only be established by analysis of MDa along with Ca125 and histological studies. elevated MDa, no and alP show positive correlations with Ca125 as the disease progresses (tab. 5, fig. 1a -c]. These markers therefore signify the progression of cancer; this information helps clinicians decide the therapy accordingly [1] .
Conclusion
The present study shows that serum Ca125 is higher in the study group compared to controls and is also highly elevated in early stages of carcinoma. These findings indicate that CA125 and ALP are potent markers for early detection of ovarian carcinoma. Increased nitrosative and oxidative stress as indicators of lipid peroxidation are closely connected with the initiation and progression of disease. The study results should be considered as beneficial for the prognosis of ovarian cancer, regardless of the specific pathology and staging of the disease. 
